Autologous whole blood injection as treatment for Covid-19 infectio
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/09/027904
- Lead Sponsor
- Dr M Christopher
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Patients in the age group of 14 years and above
2) Both male and female patients
3) Confirmed cases of COVID 19 admitted for treatment in Shifa hospital; COVID positive confirmed by RT-PCR
4) Presence of IgM antibodies through rapid test kit
5) Willing to give consent for the study and take part actively
6) Patients willing to adhere to drugs protocol as per ICMR guidelines/ WHO guidelines
7) In test arm, patients who are accepting to AWB therapy in addition to standard drugs
Exclusion Criteria
1) Children lesser than 14 years of age
2) Presence of IgG antibodies through rapid test kit
3) Patients hypersensitive to blood products or blood transfusion
4) Any Co-morbid conditions
5) Patients who are critically ill are excluded from the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method RT-PCR test turning negative is the end pointTimepoint: 14days
- Secondary Outcome Measures
Name Time Method Cytokine storm is assessed in both groupsTimepoint: Interleukin assays are assessed from time to time on scientific methods